[{"address1": "Times Square Tower", "address2": "Suite 2503 7 Times Square", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "646 200 5278", "website": "https://www.sellaslifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Angelos M. Stergiou M.D., ScD h.c.", "age": 48, "title": "Founder, President, CEO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 904243, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Thomas Burns CPA", "age": 39, "title": "Senior VP & CFO", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 505158, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy E. Yeung", "title": "VP of Legal Affairs, Head of Compliance & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dragan  Cicic M.D., MBA", "age": 61, "title": "Senior Vice President of Clinical Development", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 466430, "exercisedValue": 0, "unexercisedValue": 55739}, {"maxAge": 1, "name": "Mr. Andrew  Elnatan", "title": "Senior VP of Regulatory Affairs, CMC & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.21, "open": 1.13, "dayLow": 1.13, "dayHigh": 1.21, "regularMarketPreviousClose": 1.21, "regularMarketOpen": 1.13, "regularMarketDayLow": 1.13, "regularMarketDayHigh": 1.21, "payoutRatio": 0.0, "beta": 2.435, "forwardPE": -2.7906978, "volume": 556933, "regularMarketVolume": 556933, "averageVolume": 2581321, "averageVolume10days": 751080, "averageDailyVolume10Day": 751080, "bid": 0.8568, "ask": 1.48, "bidSize": 2, "askSize": 2, "marketCap": 94298400, "fiftyTwoWeekLow": 0.77, "fiftyTwoWeekHigh": 1.84, "fiftyDayAverage": 1.1996, "twoHundredDayAverage": 1.1954, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 64707196, "profitMargins": 0.0, "floatShares": 70127196, "sharesOutstanding": 78582000, "sharesShort": 7806570, "sharesShortPriorMonth": 9805787, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.099300005, "heldPercentInsiders": 0.00166, "heldPercentInstitutions": 0.085360005, "shortRatio": 2.9, "shortPercentOfFloat": 0.0995, "impliedSharesOutstanding": 78582000, "bookValue": 0.247, "priceToBook": 4.8582997, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -32280000, "trailingEps": -0.5, "forwardEps": -0.43, "lastSplitFactor": "1:50", "lastSplitDate": 1573171200, "52WeekChange": 0.15384614, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 1.2, "targetHighPrice": 7.5, "targetLowPrice": 4.0, "targetMeanPrice": 5.83333, "targetMedianPrice": 6.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 21031000, "totalCashPerShare": 0.299, "totalDebt": 576000, "quickRatio": 1.982, "currentRatio": 2.265, "debtToEquity": 3.624, "returnOnAssets": -1.14452, "returnOnEquity": -5.35102, "freeCashflow": -21813000, "operatingCashflow": -33074000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "SELLAS Life Sciences Group, Inc", "longName": "SELLAS Life Sciences Group, Inc.", "regularMarketChangePercent": -0.8264455, "regularMarketPrice": 1.2, "corporateActions": [], "postMarketTime": 1742601569, "regularMarketTime": 1742587201, "exchange": "NCM", "messageBoardId": "finmb_262231850", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1205328600000, "fiftyDayAverageChange": 0.00040006638, "fiftyDayAverageChangePercent": 0.00033349983, "twoHundredDayAverageChange": 0.004600048, "twoHundredDayAverageChangePercent": 0.0038481245, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "postMarketChangePercent": -0.0416736, "postMarketPrice": 1.1995, "postMarketChange": -0.000500083, "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.13 - 1.21", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2581321, "fiftyTwoWeekLowChange": 0.43000007, "fiftyTwoWeekLowChangePercent": 0.55844164, "fiftyTwoWeekRange": "0.77 - 1.84", "fiftyTwoWeekHighChange": -0.64, "fiftyTwoWeekHighChangePercent": -0.34782606, "fiftyTwoWeekChangePercent": 15.384615, "dividendDate": 1573171200, "earningsTimestamp": 1742501101, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.43, "epsCurrentYear": -0.42333, "priceEpsCurrentYear": -2.8346682, "displayName": "SELLAS Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]